Clinical Trial Update: XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE Xpedition SV Japan PMS)

View source ↗

Summary

Clinical trial update for XIENCE Xpedition Everolimus-Eluting Coronary Stent in Japan; completed post-marketing surveillance with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease
• Ischemic Heart Disease
• Myocardial Ischemia

Drugs mentioned

• XIENCE Xpedition (everolimus-eluting coronary stent)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Ischemic Heart Disease, Angina Pectoris | Status: COMPLETED | Results posted: 2019-02-21